F2RL3 and esophageal squamous cell carcinoma: To our knowledge, we are the first to report that PAR4 activation could inhibit the viability and induce the apoptosis of ESCC cells through suppressing enrichments of DNMT1 and HDAC2 at the p16 promoter via MAPK signals.